Skip to main content
Inicio
language-selector-globe Mexico | es
Selecciona localización
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Mexico
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Novartis México 
      • Novartis en México 
      • Nuestra Estrategia 
      • Cultura y Asociados 
      • Equipo Directivo 
      • Contáctanos 
      Profesionales en laboratorio Novartis México
    • Nuestro Compromiso con México 
      • Impacto en México 
      • Financiamiento Externo 
      • Ética, Riesgo y Cumplimiento 
      • Acceso 
      • Sostenibilidad Ambiental 
      • Salud Global 
      Paciente y profesional de la salud tomándose las manos Nuestro Compromiso con México
    • Sala de Prensa 
      • Contacto para Prensa 
      Profesional trabajando en laboratorio Sala de Prensa
    • Somos el Lugar para Crecer 
      • Oportunidades Laborales 
      • Nuestra Propuesta de Valor 
      • Nuestra Forma de Trabajo 
      • Bienestar 
      • Diversidad e Inclusión (D&I) 
      • Programas de Atracción de Talento 
      • Rankings y Certificaciones 
      Personas hablando en una sala de juntas Somos el Lugar para Crecer
    Imagen panorámica de campo de agave en México Inicio
  1. Inicio
  2. Somos el Lugar para Crecer
  3. Oportunidades Laborales
  • Sort by Sort ascending
  • Título profesional
  • Sitio Sort descending
  • Ubicación
  • División
  • Negocio
  • Functional Area
  • Fecha de publicación
Título profesional Sitio Sort descending Ubicación División Negocio Functional Area Fecha de publicación
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Ventas Sep 24, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Ventas Sep 24, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Ventas Sep 24, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Ventas Sep 24, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Ventas Sep 24, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Ventas Sep 24, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Ventas Sep 24, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Ventas Sep 24, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Ventas Sep 24, 2024
First Line Manager / District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Ventas Oct 09, 2024
县域主任/县域主管 Haerbin (Heilongjiang Province) China International Innovative Medicines Ventas Oct 10, 2024
Senior MR Haikou (Hainan Province) China International Innovative Medicines Ventas Sep 05, 2024
(高级)医药代表 /(资深)产品专员 Haikou (Hainan Province) China International Innovative Medicines Ventas Oct 17, 2024
Sr. Manager, ITOT Site Lead Haiyan (Zhejiang Province) China Operations CTS Technology Transformation Sep 03, 2024
Manager, Reg&Dev Policy Japan​ Head Office (Japan) (Pharmaceuticals) Japón Development Innovative Medicines Research & Development Sep 12, 2024
P&O Business Partner Development & Biomedical Research Japan Head Office (Japan) (Pharmaceuticals) Japón People & Organization Innovative Medicines Recursos humanos Sep 03, 2024
TA Strategy Lead - Hematology Head Office (Japan) (Pharmaceuticals) Japón International Innovative Medicines Márketing Jun 26, 2024
Agile Project Management Lead Head Office (Japan) (Pharmaceuticals) Japón International Innovative Medicines Technology Transformation Jul 01, 2024
Sr. TA Strategy Lead (Renal Therapy Area) Head Office (Japan) (Pharmaceuticals) Japón International Innovative Medicines Márketing Aug 07, 2024
Associate Director Pipeline Management Head Office (Japan) (Pharmaceuticals) Japón Development Innovative Medicines Research & Development Jul 10, 2024
Japan Program Manager Head Office (Japan) (Pharmaceuticals) Japón Development Innovative Medicines Research & Development Jul 10, 2024
Senior Lead, TA Medical(General Medicines) Head Office (Japan) (Pharmaceuticals) Japón International Innovative Medicines Research & Development May 27, 2024
Clinical Biospecimen Senior Scientist Head Office (Japan) (Pharmaceuticals) Japón Development Innovative Medicines Research & Development Sep 03, 2024
Associate, Record-to-Report Head Office (Japan) (Pharmaceuticals) Japón Finance CTS Auditoría y Finanzas Jun 26, 2024
Lead, Medical Excellence Head Office (Japan) (Pharmaceuticals) Japón International Innovative Medicines Research & Development Jul 02, 2024
TME Profiling Head Office (Japan) (Pharmaceuticals) Japón Biomedical Research Pharma Research Research & Development Jul 07, 2024
Clinical Sciences Trial Leader Head Office (Japan) (Pharmaceuticals) Japón Biomedical Research Pharma Research Research & Development Jul 10, 2024
Lead, RWE and Evidence Excellence Head Office (Japan) (Pharmaceuticals) Japón International Innovative Medicines Research & Development Jul 10, 2024
Senior Statistical Programmer Head Office (Japan) (Pharmaceuticals) Japón Development Innovative Medicines Research & Development Jul 18, 2024
Associate/Manager, MSL(Oncology) Head Office (Japan) (Pharmaceuticals) Japón International Innovative Medicines Research & Development Jul 22, 2024
Associate, Country QA Compliance Head Office (Japan) (Pharmaceuticals) Japón Operations Innovative Medicines Quality Oct 22, 2024
Lead/Associate, CX Content Creation Head Office (Japan) (Pharmaceuticals) Japón International Innovative Medicines Márketing Oct 20, 2024
TA Strategy Lead - GenMed Head Office (Japan) (Pharmaceuticals) Japón International Innovative Medicines Márketing Oct 02, 2024
CX strategy Head Office (Japan) (Pharmaceuticals) Japón International Innovative Medicines Márketing Oct 04, 2024
TA Strategy Lead, RLT (Prostate Cancer) Head Office (Japan) (Pharmaceuticals) Japón International Innovative Medicines Márketing Oct 07, 2024
Lead, Integrated Insights & Planning_市場調査 Head Office (Japan) (Pharmaceuticals) Japón International Innovative Medicines Márketing Oct 07, 2024
Manager, Financial Control & Compliance (FC&C) Head Office (Japan) (Pharmaceuticals) Japón Finance CTS Auditoría y Finanzas Oct 06, 2024
Associate, TA Medical (General Medicines) Head Office (Japan) (Pharmaceuticals) Japón International Innovative Medicines Research & Development Oct 07, 2024
Head Regulatory Writing Head Office (Japan) (Pharmaceuticals) Japón Development Innovative Medicines Research & Development Oct 07, 2024
Japan Program Head (Neuroscience & GTx) Head Office (Japan) (Pharmaceuticals) Japón Development Innovative Medicines Research & Development Oct 16, 2024
Japan Program Head (Immunology) Head Office (Japan) (Pharmaceuticals) Japón Development Innovative Medicines Research & Development Oct 16, 2024
Manager, TRD Project management Head Office (Japan) (Pharmaceuticals) Japón Development Innovative Medicines Research & Development Oct 16, 2024
Associate Clinical Project Manager Head Office (Japan) (Pharmaceuticals) Japón Development Innovative Medicines Research & Development Oct 18, 2024
Solution Design Head Office (Japan) (Pharmaceuticals) Japón International Innovative Medicines Márketing Sep 03, 2024
Associate/Manager, MSL (Cardiovascular) Head Office (Japan) (Pharmaceuticals) Japón International Innovative Medicines Research & Development Aug 20, 2024
Medical Field Trainer Head Office (Japan) (Pharmaceuticals) Japón International Innovative Medicines Research & Development Aug 29, 2024
Study Leader Head Office (Japan) (Pharmaceuticals) Japón Development Innovative Medicines Research & Development Sep 05, 2024
Group Manager, MSL Head Office (Japan) (Pharmaceuticals) Japón International Innovative Medicines Research & Development Sep 05, 2024
Japan Program Clinical Head (IMM) Head Office (Japan) (Pharmaceuticals) Japón Biomedical Research Innovative Medicines Research & Development Sep 10, 2024
SSO Feasibility Manager Head Office (Japan) (Pharmaceuticals) Japón Development Innovative Medicines Research & Development Oct 21, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 42
  • › Next page

Novartis México

Conoce Novartis
  • Nuestro Compromiso con México
  • Sala de Prensa
  • Somos el Lugar para Crecer
Nuestro Compromiso
  • Impacto en México
  • Acceso
  • Sostenibilidad Ambiental
Talento
  • Oportunidades Laborales
  • Nuestra forma de Trabajo
  • Diversidad e Inclusión (D&I)
  • Programas de Atracción de Talento
Footer Bottom
© 2024 Novartis MX
  • Aviso de Privacidad
  • Condiciones de uso
  • Configuración de cookies
  • Mapa del sitio
  • Accesibilidad
Directorio de Novartis
Sitio dirigido a audiencia local.
COFEPRIS Permiso de Publicidad: 233300201B1273
Consulte a su médico